Contact lens displaying improved vision attributes

US12486348B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12486348-B2
Application numberUS-202016938117-A
CountryUS
Kind codeB2
Filing dateJul 24, 2020
Priority dateAug 30, 2019
Publication dateDec 2, 2025
Grant dateDec 2, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Described are contact lenses that contain high energy visible (HEV) light absorbing compounds and their use for improving one or more vision attributes.

First claim

Opening claim text (preview).

We claim: 1 . A contact lens that is a free radical reaction product of a reactive mixture comprising: one or more polymerizable compounds suitable for making the contact lens; and a high energy visible (HEV) light absorbing compound, wherein the contact lens transmits from 0 percent to 70 percent of light across a wavelength range of 400 to 409 nm, wherein the contact lens further comprises a UV absorbing compound that is a benzophenone, a benzotriazole, a triazine, a substituted acrylonitrile, a salicyclic acid, a benzoic acid, a cinnamic acid, a chalcone, a dypnone, a crotonic acid, or mixtures thereof, and wherein the contact lens provides a greater reduction in halo size for wearers in a 40 to 65 age group than for wearers in an 18-39 age group, when compared to a control lens that does not contain the HEV light absorbing compound. 2 . The contact lens of claim 1 wherein the contact lens transmits 45 percent or less of light across a wavelength range of 280 to 399 nm. 3 . The contact lens of claim 1 that transmits at least 80 percent of light across a wavelength range of 450 to 800 nm. 4 . The contact lens of claim 1 that is photostable. 5 . The contact lens of claim 1 wherein the high energy visible light absorbing compound is a static compound. 6 . The contact lens of claim 1 wherein the high energy visible light absorbing compound comprises a compound of formula I: wherein: m and n are independently 0, 1, 2, 3, or 4; T is a bond, O, or NR; Y is a linking group; P g is a polymerizable group; R at each occurrence is independently H, C 1 -C 6 alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, or Y—P g ; and R 1 and R 2 , when present, are independently at each occurrence C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 1 -C 6 thioalkyl, C 3 -C 7 cycloalkyl, aryl, halo, hydroxy, amino, NR 3 R 4 , or benzyl, wherein R 3 and R 4 are independently H or C 1 -C 6 alkyl, or two adjacent R 1 or R 2 groups, together with the carbon atoms to which they are attached, combine to form a cycloalkyl or aryl ring. 7 . The contact lens of claim 6 wherein m and n are each independently 0 or 1. 8 . The contact lens of claim 6 wherein Y at each occurrence is independently alkylene, cycloalkylene, heterocycloalkylene, arylene, heteroarylene, oxaalkylene, alkylene-amide-alkylene, alkylene-amine-alkylene, or combinations thereof. 9 . The contact lens of claim 6 wherein P g comprises styryl, vinyl carbonate, vinyl ether, vinyl carbamate, N-vinyl lactam, N-vinylamide, (meth)acrylate, or (meth)acrylamide. 10 . The contact lens of claim 1 wherein the UV absorbing compound comprises a benzophenone, a benzotriazole, a triazine, a substituted acrylonitrile or mixtures thereof. 11 . The contact lens of claim 1 wherein the polymerizable compound suitable for making the contact lens comprises a hydrophilic component, a silicone-containing component, or mixtures thereof. 12 . A method for improving a vision attribute in a contact lens wearer, the method comprising: providing the contact lens wearer with a contact lens according to claim 1 , wherein the vision attribute is selected from one or more of photostress recovery time, glare discomfort, glare disability threshold, heterochromatic contrast threshold, halo size, starburst size, and light scattering. 13 . A method for improving a vision attribute in a contact lens wearer, the method comprising: providing the contact lens wearer with a contact lens that is a free radical reaction product of a reactive mixture comprising: one or more polymerizable compounds suitable for making the contact lens; and a high energy visible (HEV) light absorbing compound, a UV absorbing compound that is a benzophenone, a benzotriazole, a triazine, a substituted acrylonitrile, a salicyclic acid, a benzoic acid, a cinnamic acid, a chalcone, a dypnone, a crotonic acid, or mixtures thereof, wherein the contact lens provides a greater reduction in halo size for wearers in a 40 to 65 age group than for wearers in an 18-39 age group, when compared to a control lens that does not contain the HEV light absorbing compound. 14 . The method of claim 12 wherein improving a vision attribute comprises an improvement in the vision attribute as observed by a contact lens wearer when compared to a contact lens that transmits at least 90 percent of light across the wavelength range of 400 to 409 nm. 15 . The contact lens of claim 1 wherein the HEV light absorbing compound comprises: 2-(2-cyano-2-(9H-thioxanthen-9-ylidene)acetamido)ethyl methacrylate; 2-(2-cyano-2-(9H-thioxanthen-9-ylidene)acetamido)ethyl acrylate; N-(2-(2-cyano-2-(9H-thioxanthen-9-ylidene)acetamido)ethyl)methacrylamide; N-(2-(2-cyano-2-(9H-thioxanthen-9-ylidene)acetamido)ethyl)acrylamide; 2-(2-cyano-N-methyl-2-(9H-thioxanthen-9-ylidene)acetamido)ethyl methacrylate; 2-cyano-2-(9H-thioxanthen-9-ylidene)-N-(2-(N-vinylacetamido)ethyl)acetamide; 2-(2-cyano-2-(9H-thioxanthen-9-ylidene)acetamido)-2-methylpropyl methacrylate; (E)-2-(2-cyano-2-(2,4-dichloro-9H-thioxanthen-9-ylidene)acetamido)ethyl methacrylate; (E)-2-(2-(2-chloro-9H-thioxanthen-9-ylidene)-2-cyanoacetamido)ethyl methacrylate; (E)-2-(2-cyano-2-(2-isopropyl-9H-thioxanthen-9-ylidene)acetamido)ethyl methacrylate; (E)-2-(2-cyano-2-(4-isopropyl-9H-thioxanthen-9-ylidene)acetamido)ethyl methacrylate; 2-(2-cyano-2-(9H-thioxanthen-9-ylidene)acetoxy)ethyl methacrylate; or mixtures thereof.

Assignees

Inventors

Classifications

  • with the reactive group not directly attached to a heterocyclic ring · CPC title

  • G02C7/104Primary

    having spectral characteristics for purposes other than sun-protection · CPC title

  • Contact lenses · CPC title

  • Contact lenses for the eyes (disinfection or sterilisation of contact lenses A61L12/00) · CPC title

  • Filters, e.g. for facilitating adaptation of the eyes to the dark; Sunglasses · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12486348B2 cover?
Described are contact lenses that contain high energy visible (HEV) light absorbing compounds and their use for improving one or more vision attributes.
Who is the assignee on this patent?
Johnson & Johnson Vision Care
What technology area does this patent fall under?
Primary CPC classification G02C7/104. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Dec 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).